David John Mott : Citation Profile


Are you David John Mott?

1

H index

0

i10 index

5

Citations

RESEARCH PRODUCTION:

4

Articles

3

Papers

RESEARCH ACTIVITY:

   2 years (2018 - 2020). See details.
   Cites by year: 2
   Journals where David John Mott has often published
   Relations with other researchers
   Recent citing documents: 3.    Total self citations: 0 (0 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pmo1129
   Updated: 2021-03-01    RAS profile: 2020-03-12    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Shah, Koonal (3)

Devlin, Nancy (3)

Authors registered in RePEc who have co-authored more than one work in the last five years with David John Mott.

Is cited by:

Shah, Koonal (2)

Vass, Caroline (1)

Graf von der Schulenburg, Johann (1)

Devlin, Nancy (1)

Cites to:

Shah, Koonal (5)

Lancsar, Emily (3)

Lorgelly, Paula (2)

Fiebig, Denzil (2)

Feng, Yan (2)

Towse, Adrian (2)

Devlin, Nancy (2)

Tsuchiya, Aki (2)

Shah, Kalim (1)

Wildman, John (1)

Vass, Caroline (1)

Main data


Where David John Mott has published?


Journals with more than one article published# docs
PharmacoEconomics - Open2

Working Papers Series with more than one paper published# docs
Consulting Reports / Office of Health Economics2

Recent works citing David John Mott (2021 and 2020)


YearTitle of citing document
2020An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values. (2020). Devlin, Nancy ; Kreimeier, Simone ; Ramos-Goi, Juan Manuel ; Shah, Koonal K. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:7:d:10.1007_s10198-020-01205-9.

Full description at Econpapers || Download paper

2020Should health technology assessment be more patient centric? If so, how?. (2020). Tarricone, Rosanna ; Torbica, Aleksandra ; Drummond, Michael. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:8:d:10.1007_s10198-020-01182-z.

Full description at Econpapers || Download paper

2020HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies. (2020). Shah, Koonal ; Graf von der Schulenburg, Johann ; Shen, Jie ; Durand-Zaleski, Isabelle ; Ratcliffe, Mark ; Coyle, Doug ; Pemberton-Whiteley, Zack ; Palmer, Stephen ; Moutie, Anne-Sophie ; Meunier, Aurelie ; Longworth, Louise ; Greiner, Wolfgang ; Zhao, Kun ; Garrison, Louis ; Sproule, Doug ; Farrington, Jasmine. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:9:d:10.1007_s10198-020-01212-w.

Full description at Econpapers || Download

Works by David John Mott:


YearTitleTypeCited
2018Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment In: Consulting Reports.
[Full Text][Citation analysis]
paper1
2019Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ? In: Research Papers.
[Full Text][Citation analysis]
paper1
2020A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2018Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind? In: The Patient: Patient-Centered Outcomes Research.
[Full Text][Citation analysis]
article3
2019Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
article0
2019Correction to: Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated November, 2 2021. Contact: CitEc Team